HomeCompareALRT vs ARCC

ALRT vs ARCC: Dividend Comparison 2026

ALRT yields 6666.67% · ARCC yields 10.82%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ALRT wins by $1028095347812062.00M in total portfolio value
10 years
ALRT
ALRT
● Live price
6666.67%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1028095347812062.00M
Annual income
$998,628,545,336,266,700,000.00
Full ALRT calculator →
ARCC
Ares Capital Corporation
● Live price
10.82%
Share price
$17.74
Annual div
$1.92
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$1.16
Full ARCC calculator →

Portfolio growth — ALRT vs ARCC

📍 ALRT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodALRTARCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ALRT + ARCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ALRT pays
ARCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ALRT
Annual income on $10K today (after 15% tax)
$566,666.67/yr
After 10yr DRIP, annual income (after tax)
$848,834,263,535,826,600,000.00/yr
ARCC
Annual income on $10K today (after 15% tax)
$919.95/yr
After 10yr DRIP, annual income (after tax)
$0.99/yr
At 15% tax rate, ALRT beats the other by $848,834,263,535,826,600,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ALRT + ARCC for your $10,000?

ALRT: 50%ARCC: 50%
100% ARCC50/50100% ALRT
Portfolio after 10yr
$514047673906031.00M
Annual income
$499,314,272,668,133,360,000.00/yr
Blended yield
97.13%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

ALRT
No analyst data
ARCC
Analyst Ratings
24
Buy
7
Hold
Consensus: Buy
Price Target
$21.88
+23.3% upside vs current
Range: $21.00 — $23.00
Altman Z
0.8
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ALRT buys
0
ARCC buys
0
No recent congressional trades found for ALRT or ARCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricALRTARCC
Forward yield6666.67%10.82%
Annual dividend / share$2.00$1.92
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$1028095347812062.00M$24.5K
Annual income after 10y$998,628,545,336,266,700,000.00$1.16
Total dividends collected$1026118102492338.88M$1.1K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: ALRT vs ARCC ($10,000, DRIP)

YearALRT PortfolioALRT Income/yrARCC PortfolioARCC Income/yrGap
1← crossover$677,367$666,666.67$11,381$541.15+$666.0KALRT
2$42,928,313$42,203,530.63$12,621$284.08+$42.92MALRT
3$2,545,616,701$2,499,683,405.64$13,827$145.31+$2545.60MALRT
4$141,255,910,403$138,532,100,533.89$15,062$73.43+$141255.90MALRT
5$7,335,374,338,812$7,184,230,514,680.15$16,364$36.89+$7335374.32MALRT
6$356,516,885,536,661$348,668,034,994,132.70$17,757$18.49+$356516885.52MALRT
7$16,218,956,689,966,618$15,837,483,622,442,392.00$19,258$9.25+$16218956689.95MALRT
8$690,711,023,145,868,900$673,356,739,487,604,600.00$20,880$4.63+$690711023145.85MALRT
9$27,539,067,734,387,980,000$26,800,006,939,621,900,000.00$22,636$2.32+$27539067734387.95MALRT
10$1,028,095,347,812,062,000,000$998,628,545,336,266,700,000.00$24,539$1.16+$1028095347812062.00MALRT

ALRT vs ARCC: Complete Analysis 2026

ALRTStock

ALR Technologies Inc., a data management company, develops diabetes care solutions for human and animal health in the United States. It provides Diabetes Management System, a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring, and diabetes test supplies. The company also offers Continuous Glucose Monitoring (CGM), a medical device that is worn on the body of a diabetic subject for blood sugar readings; and GluCurve Pet CGM to address an unmet need in diabetes care for felines and canines used by veterinarians in animal health, as well as Prediabetes System, which provides patients with educational videos and supplemental content formatted for mobile devices and a private online community to discuss disease management. Its primary business markets are health care providers, the providers of health insurance, and the providers of disease and case management services, including the home care industry. The company was formerly known as Mo Betta Corp. and changed its name to ALR Technologies Inc. in December 1998. ALR Technologies Inc. was incorporated in 1987 and is based in Richmond, Virginia.

Full ALRT Calculator →

ARCCBDC

Ares Capital Corporation is a business development company specializing in acquisition, recapitalization, mezzanine debt, restructurings, rescue financing, and leveraged buyout transactions of middle market companies. It also makes growth capital and general refinancing. It prefers to make investments in companies engaged in the basic and growth manufacturing, business services, consumer products, health care products and services, and information technology service sectors. The fund will also consider investments in industries such as restaurants, retail, oil and gas, and technology sectors. It focuses on investments in Northeast, Mid-Atlantic, Southeast and Southwest regions from its New York office, the Midwest region, from the Chicago office, and the Western region from the Los Angeles office. The fund typically invests between $20 million and $200 million and a maximum of $400 million in companies with an EBITDA between $10 million and $250 million. It makes debt investments between $10 million and $100 million The fund invests through revolvers, first lien loans, warrants, unitranche structures, second lien loans, mezzanine debt, private high yield, junior capital, subordinated debt, and non-control preferred and common equity. The fund also selectively considers third-party-led senior and subordinated debt financings and opportunistically considers the purchase of stressed and discounted debt positions. The fund prefers to be an agent and/or lead the transactions in which it invests. The fund also seeks board representation in its portfolio companies.

Full ARCC Calculator →
📬

Get this ALRT vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ALRT vs SCHDALRT vs JEPIALRT vs OALRT vs KOALRT vs MAINALRT vs HTGCALRT vs GBDCALRT vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.